LifeSensors, Inc. is a biotechnology company focused on discovering, developing, and commercializing innovations in an important family of proteins consisting of ubiquitin and ubiquitin-like proteins (UBL). We develop novel technologies that use SUMO (Small Ubiquitin-like MOdifier) to overcome bottlenecks in protein production, and are the leading producer of tools to facilitate the study of the Ubiquitin-Proteasome Pathway.

The company has expanded its production capabilities to assist customers and partners improve the quality and quantity of their protein production. Leveraging its active protein production capabilities, LifeSensors is proud to develop Functional Protein Arrays and to introduce first-in-class human de-ubiquitylase arrays (DUB Arrays). These protein arrays are used for drug discovery and diagnostics markets.

Founded in 1996, LifeSensors is located in Great Valley Corporate Center 35 miles west of Philadelphia, Pennsylvania, USA. The company holds patents covering the use of SUMO and other UBLs as gene fusion tags to improve protein expression and purification; it has filed for and licensed patents for novel assay technologies for de-ubiquitylases and ubiquitin ligases.

Ubiquitin Affinity Matrices (TUBEs, UbiQuant® ELISA, VU-1® antibody), SUMOpro®, SUMOpro3® & SUMOstar®, Ubiquitin/Conjugation Assays/Enzymes (E1s, E2s and E3s), DiUbiquitin IQF Substrate (IQF-DiUb), Dub Chip Microarrays, Ubl-Pathway Inhibitors (PR-619)